BFM
ANAB icon

Boothbay Fund Management’s AnaptysBio ANAB Stock Holding History

Boothbay Fund Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-27,402
Closed -$839K – 1944
2025
Q3 		$839K Buy
+27,402
New +$629K 0.01% 908
2021
Q4 		– Sell
-12,260
Closed -$332K – 1838
2021
Q3 		$332K Sell
12,260
-4,875
-28% -$124K 0.01% 1276
2021
Q2 		$444K Buy
+17,135
New +$411K 0.01% 1063
2021
Q1 		– Sell
-13,542
Closed -$342K – 1515
2020
Q4 		$291K Buy
+13,542
New +$329K 0.01% 961
2020
Q1 		– Sell
-29,775
Closed -$484K – 837
2019
Q4 		$484K Buy
+29,775
New +$704K 0.04% 496
2019
Q2 		– Sell
-16,000
Closed -$1.15M – 724
2019
Q1 		$1.17M Buy
+16,000
New +$1.1M 0.11% 203

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Boothbay Fund Management's ANAB Position: Q4 2025 in Review

Boothbay Fund Management sold out of AnaptysBio (ANAB) in Q4 2025, closing a stake of 27,402 shares — an estimated $839K sold.

Boothbay Fund Management first reported a position in ANAB in Q1 2019 and held it in 6 quarters. The position peaked at $1.17M in Q1 2019. 179 funds tracked by Wall St. Rank hold ANAB as of Q4 2025.

  • Boothbay Fund Management reported no remaining AnaptysBio position as of Q4 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 27,402 AnaptysBio shares in Q4 2025, an estimated $839K.
  • Boothbay Fund Management first reported a position in AnaptysBio in Q1 2019 and held it in 6 quarters.
  • Boothbay Fund Management's AnaptysBio position peaked at $1.17M in Q1 2019.
  • 179 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2025.

Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.